Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Oct;84(4):1130-3.
doi: 10.1172/JCI114276.

Rat renal epinephrine synthesis

Affiliations
Free PMC article

Rat renal epinephrine synthesis

M G Ziegler et al. J Clin Invest. 1989 Oct.
Free PMC article

Abstract

Rats that underwent adrenal demedullation had a 93% decrease in plasma epinephrine (E) levels, but did not decrease their renal E. Even further treatment with 6-hydroxydopamine and reserpine failed to lower renal E levels. Similarly, urine E levels failed to decrease after adrenal demedullation and renal denervation. There is a renal E-synthesizing enzyme that differs from adrenal phenylethanolamine-N-methyltransferase (PNMT) in that it is only weakly inhibited by SKF 29661 and can synthesize epinine from dopamine, while adrenal PNMT does so poorly. When an adrenalectomized rat received intravenous [3H]methionine, its urine contained radioactivity that appeared to be [3H]E, with small amounts of [3H]epinine. However, after [3H]methionine was infused in the renal artery, the major product in urine appeared to be [3H]epinine, with a small amount of [3H]E. Adrenal demedullation induced renal E synthesis, but denervation returned the rate of renal E synthesis to control values. The combination of adrenal demedullation, 6-hydroxydopamine, and reserpine treatments increased renal E-forming activity to 350% of control. We conclude that appreciable portions of renal and urinary E are synthesized in the kidney by an enzyme distinct from PNMT. The enzyme is induced by some treatments that lower E and NE levels.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Invest. 1952 May;31(5):499-506 - PubMed
    1. Acta Endocrinol (Copenh). 1961 Nov;38:441-8 - PubMed
    1. Hypertension. 1985 Jan-Feb;7(1):47-52 - PubMed
    1. J Pharmacol Exp Ther. 1987 Aug;242(2):455-63 - PubMed
    1. Biochem Biophys Res Commun. 1986 Nov 26;141(1):334-9 - PubMed

Publication types